Statistics
Annual Publications by Category
Summary of Budget vs Expenditure per vote for all research grants
Last 3 Projects
Project Title Progress Status
Unravelling the Pharmacogenetics of SGLT-2 Inhibitors: Towards Precision Medicine for Cardioprotection in Type 2 Diabetes Mellitus
new
Unraveling The Role Of Endometrial Cancer Fibroblasts In Lipogenic-driven Hormone Resistance In Obese Women Using Metabolic Fingerprinting Approach
on going
Investigating the role of SGLT2 inhibitors on epicardial adipose tissues (EAT) on cardiometabolic parametres in type 2 diabetic patients
end
This information is generated from Research Grant Management System
Latest Publications
2024

Spectroscopic diagnosis and metabolite characterization of cisplatin resistance regulated by FDFT1 in bladder cancer tissue

2024

Ethnic disparities and its association between epicardial adipose tissue thickness and cardiometabolic parameters

2023

The associations of cardiac functions with glycaemic control parameters in type 2 diabetic (T2DM) patients with coronary artery disease (CAD) following sodium-glucose cotransporter-2 (SGLT-2) inhibitors: A preliminary quasi-experimental cohort analysis

2023

Distinct Lipid Phenotype of Cancer-Associated Fibroblasts (CAFs) Isolated From Overweight/Obese Endometrial Cancer Patients as Assessed Using Raman Spectroscopy

2013

Impaired metabolic and functional recovery of the type 2 diabetic heart following hypoxia.

2012

Modification of PPARα activity is detrimental to cardiac function during chronic hypoxia: critical role of PPARα on cardiac substrate metabolism

2012

Regulation of PPARα by Hypoxia Regulation Factors (HIF)

2010

PPARα is essential for cardiac adaptation to chronic hypoxia.